CMS proposes broadening criteria for price control, while CBO warns that such controls could discourage investment in the sector.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Medicare →

  US federal health insurance

  • Advocates are calling for guardrails on AI development following a recent hack of the Medicare system.Mon 15:20
  • Leaders call for slowing AI development pace, concurrent with an AI model built by OpenAI being hacked via the Medicare portal.Mon 15:20
• Congressional Budget Office →

  government agency

  • Donald Trump and Scott Bessent commented on the budget, monitoring fiscal health and policy levers during the presidential tenure.Mon 16:08
  • Trump is attempting to incorporate costs into a spending bill, involving the Congressional Budget Office.Sun 00:25

Related events

• CMS introduced the Medicare drug price negotiation program, and companies are facing challenges regarding pricing and market access.Aug 19
• Administration proposes a rule to manage Medicare drug costs, reported by the Associated Press.Jul 2
• The FDA is monitoring drug industry practices and pricing, utilizing studies published by JAMA.Sep 10
• CMS controls the Part D rate stabilization program and urges officials to expand negotiation powers.Aug 6
• AARP advocated for Medicare to negotiate drug prices in Washington, D.C.Jul 17